section name header

Basic Information

AUTHOR: Daniel K. Asiedu, MD, PhD, FACP

Figure E1 The metabolism and actions of vitamin D.

!!flowchart!!

The primary source of vitamin D in humans is photoactivation in the skin of 7-dehydrocholesterol to cholecalciferol, which is then converted first in the liver to 25-hydroxyvitamin D and subsequently in the kidney to the much more active form, 1,25-dihydroxycholecalciferol (1,25[OH]2,D3). Regulation of the latter step is by parathyroid hormone (PTH), phosphate (PO4), and feedback inhibition by 1,25(OH)2,D3. This step can also occur in lymphomatous and sarcoid tissue, resulting in the hypercalcemia that may complicate these diseases. UV, Ultraviolet.

From Ballinger A: Kumar & Clark’s essentials of clinical medicine, ed 6, Edinburgh, 2012, Saunders.

Definition

Vitamin D deficiency is characterized by hypocalcemia and/or hypophosphatemia leading to impaired bone mineralization. It is classified as a serum 25-hydroxyvitamin D (25[OH]D) level of <20 ng/ml (50 nmol/L). This standard definition of vitamin D deficiency has been recently challenged, and some endocrinologists recommend a cutoff of 12 mg/ml for vitamin D deficiency. Vitamin D insufficiency is defined as a 25(OH)D between 12 and 20 ng/ml.

The consequences of vitamin D deficiency include:

  • Bone disease (rickets, osteoporosis, low bone mass)
  • May impair reproductive success
  • Decrease the ability to combat infection (especially tuberculosis, influenza, viral infection)
  • May induce or worsen autoimmune disorders
  • May increase the incidence of death due to heart disease, inflammatory bowel disease, fracture, and cancer of the breast, colon, and prostate
  • Subclinical vitamin D deficiency may occur in developed countries and be associated with increased fall risk and osteoporosis
Synonyms

The sunshine vitamin

The antirachitic factor

Cholecalciferol

ICD-10CM CODE
E55.9Vitamin D deficiency, unspecified
Epidemiology & Demographics
Incidence

  • Vitamin D insufficiency is very high among older adults and hospitalized and institutionalized people.
  • Worldwide deficiency and insufficiency affect about 1 billion people.
  • Children and young adults: 40% to 50% of preadolescent Caucasian girls, and Hispanic and African American adolescents, are vitamin D deficient.
Prevalence

41.6% of adults (at least 20 yr old) have 25(OH)D levels <20 ng/dl.

Predominant Sex & Age

  • Decreased skin production of vitamin D with age
  • Increased prevalence among darker-skinned individuals
Peak Incidence

In the U.S., 40% to 100% of the elderly are vitamin D deficient.

Sixty percent of nursing home residents may be vitamin D deficient.

Risk Factors

  • Age (due to decreased ability to produce D3)
  • Sunshine-deficient areas (geographic location, living in higher latitudes)
  • Dark-skinned individuals (melanin competes with vitamin D3 precursors for UV photons and thus decreases pre-D3 formation)
  • Obese individuals
  • Institutionalized individuals
  • Pregnant and lactating women
  • Use of sunscreen (sun radiation that causes skin cancer also produces pre-vitamin D3 in skin)
  • Patients on certain medications that antagonize vitamin D action (phenobarbital, phenytoin)
  • Intestinal resection
  • Severe chronic liver diseases (such as cirrhosis)
  • Kidney disease (e.g., nephritic syndrome)
  • Sarcoidosis and lymphomas (increased catabolism of 25[OH]D to 1,25[OH]2D)
  • Intestinal malabsorption disease (caused by celiac sprue, cystic fibrosis, Whipple disease)
Physical Findings & Clinical Presentation

  • Clinical presentation of vitamin D deficiency is dependent on the duration and severity of deficiency
  • Most patients with mild to moderate vitamin D deficiency are asymptomatic
  • Severe deficiency may lead to rickets (in children), osteomalacia (in adults), bone demineralization, hypokalemia, and phosphaturia
  • Mild deficiency can lead to hypocalcemia and hyperparathyroidism
  • Rickets: Seen in children; caused by defective mineralization in the skeleton (Fig. E2)
    1. Bowing of the legs
    2. Leg bone pain
    3. Delayed growth
    4. Seizure due to hypocalcemia
  • Osteomalacia: Seen in adults with severe and prolonged vitamin D deficiency
    1. Periosteal bone pain (best detected by putting firm pressure on tibia or sternal bones)
    2. Proximal muscle weakness
    3. Chronic muscle aches/pain
  • Fracture with very minimal trauma (brittle and easily broken bones)
  • Severe hypocalcemia: Especially in late vitamin D deficiency leading to seizure tetany
  • Hypophosphatemia
  • Paresthesia
  • Tetany
  • Muscle cramps

Figure E2 Radiographs of a Child with Vitamin D Deficiency Rickets, Demonstrating Bowing of the Femurs and Tibias (A) and Widened, Frayed, Demineralized Epiphyseal Plates (B and C)

From Hochberg MC et al: Rheumatology, ed 5, St Louis, 2011, Mosby.

Etiology

  • Inadequate exposure to sunlight, such as:
    1. During winter
    2. In nursing home and health care institution residents
    3. With excessive use of sunscreen
  • Medications: Individuals on certain medications, such as phenobarbital, phenytoin, and rifampin (antagonize vitamin D action/increase vitamin D catabolism)
  • Diseases and disease states:
    1. Diseases causing vitamin D malabsorption:
      1. Cystic fibrosis
      2. Whipple disease
      3. Celiac sprue
    2. Diseases increasing vitamin D catabolism:
      1. Lymphoma
      2. Sarcoidosis
    3. Intestinal resection
    4. Decreased 25(OH)D production:
      1. Kidney disease
      2. Liver cirrhosis

Diagnosis

Differential Diagnosis

  • Arthritis
  • Fibromyalgia
Workup

  • Population-wide screening for vitamin D deficiency is not recommended because evidence to support this practice is lacking. Appropriate to screen high-risk individuals.
  • Screening is needed for individuals at risk (osteoporosis, history of falls, obese persons, pregnant and lactating women, diseases causing vitamin D malabsorption, African Americans). Workup involves blood and urine tests as well as radiography, as outlined in the next section.

TABLE 1 Laboratory Tests

SerumURINE
CalciumPhosphorusAlkaline phosphataseCalcium
OsteoporosisNNNN
Hyperparathyroidism
PrimaryN or N or
SecondaryN or
TertiaryN or N or N or
HypoparathyroidismN
PseudohypoparathyroidismN
Rickets/osteomalacia
Vit D deficient
Vit D refractoryN
HypophosphatasiaN or NN or

Vit, Vitamin.

From Grant LA: Grainger & Allison’s diagnostic radiology essentials, ed 2, Philadelphia, 2019, Elsevier.

Laboratory Tests (Table 1

  • Serum 25(OH)D: This is the best test to determine vitamin D status.
  • Parathyroid hormone (PTH): Increased levels in vitamin D insufficiency. It is a marker of vitamin D insufficiency.
  • Increased (serum or bone) alkaline phosphatase.
  • Decreased 24-h urine calcium (patient should not be on a thiazide).
  • In patients at risk for osteomalacia [s-25(OH)D is less than 10 ng/ml], check calcium, Ph, alkaline phosphatase, PTH, basic metabolic panel, and tissue transglutaminase antibodies.
Imaging Studies

  • Radiographs may show:
    1. Pseudofractures of the pelvis, femur, metatarsals
    2. Nontraumatic fractures
  • Bone density:
    1. Decreased bone mineral density (osteopenia or osteoporosis). Note that bone mineral density is not routinely performed in patients whose only risk factor is decreased Vitamin D levels.

Treatment

Nonpharmacologic Therapy

  • Natural sources of vitamin D. These include:
    1. Exposure to sunlight. A mild sunburn is equivalent to consuming 10,000 to 25,000 IU of dietary vitamin D.
    2. Dietary sources are not enough to meet daily requirements. Oily fish such as salmon, cod, and mackerel are rich sources of vitamin D3.
  • Foods fortified with vitamin D
    1. Mainly fortified dairy products
    2. Fortified orange juice
Acute General Rx

  • Treating deficiency (general population): Cholecalciferol (vitamin D3), when available, is preferred for vitamin D supplementation
    1. 50,000 IU of vitamin D every week for 8 wk, or
    2. 6000 IU daily to achieve a serum level of 25(OH)D of at least 30 ng/ml
  • Maintenance measures after treatment (general population): 1500 to 2000 IU daily
  • Treating deficiency (obese patients, patients with malabsorption syndromes, or those taking certain medications, as indicated earlier)
    1. 10,000 IU daily maintenance dose is recommended once s-25(OH)D level exceeds 30 ng/ml.
    2. After treating deficiency, recheck 25(OH)D in 12 to 16 wk.
    3. Maintenance measures after treatment (obese patients, patients with malabsorption syndromes, or those taking certain medications, as indicated earlier): 3000 to 6000 IU daily.
    4. If deficiency persists after several attempts at treatment, try UV B light therapy.
Referral

Referral to an endocrinologist is recommended if there is no response to treatment.

Prevention

  • Food fortification with vitamin D2 or vitamin D3.
  • Adequate sun exposure, for example, exposure in the middle of the day (between 10:00 A.M. and 3:00 P.M.).
  • Use vitamin D3 for supplementation when available.
  • Vitamin D supplementation (per the Endocrine Society):
    1. Infants (age range 1 to 12 mo) require at least 400 IU/day of vitamin D
    2. Children (age range 1 to 18 yr) require 600 IU/day of vitamin D
    3. Adult supplementation (adults 19 to 70 yr): 600 IU of vitamin D daily
    4. Adult supplementation (persons 70 yr): 800 IU of vitamin D daily
    5. Exceptions: Pregnant or lactating women, obese persons, and patients on antiseizure medications, steroids, antifungals, and AIDS medications should be given 2× to 3× more vitamin D
    6. To reduce the risk of fracture and falls, the American Geriatric Society recommends a daily intake of at least 1000 IU and the National Osteoporosis Foundation 800 to 1000 IU in adults 65 yr or older
Screening

Routine screening for low-risk adults is not recommended. Screening is recommended only for individuals at high risk for vitamin D deficiency such as Blacks and Hispanics, obese individuals (body mass index >30 kg/m2), patients with osteoporosis, the elderly, and patients with certain chronic diseases (see “Risk Factors”). According to the U.S. Preventive Services Task Force, current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.

Pearls & Considerations

Related Content

Vitamin D Deficiency (Patient Information)

Osteomalacia and Rickets (Related Key Topic)

Vitamin Deficiency (Related Key Topic)

Related Content

    1. Appel LJ et al: The effects of four doses of vitamin D supplements on falls in older adults: a responsive-adaptive, randomized clinical trial, Ann Intern Med 8, 2020.
    2. Neale R.E. : The D-health trial: a randomised controlled trial of the effect of vitamin D on mortalityLancet Diabetes Endocrinol. ;10(2):120-128, 2022.
    3. Hahn J. : Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trialBMJ. ;376, 2022.
    4. Peireira-Santos M. : Obesity and vitamin D deficiency: a systematic review and meta-analysisObes Rev. ;16(4), 2015.
    5. Shah S. : Serum 25-hydroxyvitamin D insufficiency in search of a bone diseaseJ Clin Endocrinol Metab. ;102, 2017.